AbbVie
IRS: 320375147
ABBV
AbbVie is a drug company with a strong exposure to immunology and oncology.
Founded
2013 (7 years)
CEO
Richard A. Gonzalez
Investor Relations
•
SEC
Revenue
33 billion (2019)
Want to see more? Sign up!
